Royal Philips announced it has convened the Annual General Meeting of Shareholders 2023 and published the agenda with explanatory notes.
Philips convenes the Annual General Meeting of Shareholders 2023 Read More »
Incyte announced that the U.S. Food and Drug Administration has issued a complete response letter for ruxolitinib extended-release tablets, a JAK1/JAK2 inhibitor, for once-daily use in the treatment of certain types of myelofibrosis, polycythemia vera and graft-versus-host disease.
Incyte Provides Regulatory Update on Ruxolitinib Extended-Release Tablets Read More »
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, announced a corporate update and reported its annual results for the year ended December 31, 2022.
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results Read More »
Agilent Technologies Inc. announced that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease at the Victor Chang Cardiac Research Institute in Sydney, Australia.
Sobre la visibilización y el reanálisis de los datos de la investigación clínica
Escepticemia por Gonzalo Casino | Restaurar ensayos Read More »
The report comes as provider groups increasingly use artificial intelligence to combat clinician burnout and tech companies invest in healthcare data management.
Majority of healthcare leaders struggle with inefficient data, report finds Read More »
Una investigación ha examinado la influencia del consumo alimentario de fibra sobre el nivel de riesgo de desarrollar deterioro cognitivo en personas mayores con el genotipo APOE-épsilon-4 en el gen de la Apolipoproteína E, que está considerado como un factor de riesgo ge …
Consumo de fibra y riesgo de deterioro cognitivo Read More »
Novo Nordisk and Dewpoint Therapeutics have inked a deal to use the latter’s biomolecular condensates discovery platform to treat insulin resistance and diabetic complications.
Novo Nordisk Inks Deal with Dewpoint Therapeutics to Boost Diabetes Portfolio Read More »
Wednesday, the FDA approved Cidara Therapeutics and Melinta Therapeutics’ Rezzayo (rezafungin) injection to treat candidemia and invasive candidiasis.
Cidara and Melinta Win FDA Approval for First New Echinocandin in a Decade Read More »
Regulators with the CMS coded AppliedVR’s pain treatment as durable medical equipment, opening a path to insurance reimbursement for similar virtual reality devices.
VR-based pain treatment can be covered as DME, regulators say Read More »
